HCA Healthcare management check

HCA · Health Care · Health Care Facilities · CEO Hazen

Filings as of

90
Management score, ranked 8th of 487 · 1st of 60 in Health Care6 good · 1 to watch · 0 flaggedStrongest: owner returns · Weakest: pay for performance · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$296Peers$148

    What $100 became since fiscal 2021

    100100th
    Detail

    $100 invested at the start of fiscal 2021 grew to $296, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    7638th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.52 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.4% of net income

    $26.5m pay · $6.8bn net income, FY2025

    0.1%1%3%10%
    8483rd
    Detail

    $26.5m of reported pay in fiscal 2025, against $6.8bn of net income.

  • Watch

    Do they own the stock?

    Insiders are selling

    6 mo: ▲ $0 bought · ▼ $18.3m sold

    ——
    Detail

    3 insiders sold $18.3m in the last six months and none bought.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 329m2025 · 239m

    Diluted shares −6.9% a year; flagged above +2%

    0%10%20%

    Stock pay 0.5% of revenue

    100100th
    Detail

    Diluted shares changed -6.9% a year over the last three fiscal years. Stock-based pay was 0.5% of revenue in the latest year.

  • Good

    Is leadership stable?

    9 leadership filings in 3 years

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Hazen

    8056th
    Detail

    CEO in the pay table: Hazen. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 13, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$42.3m$84.6m$10020212022202320242025$296$148

Pay tied most to Adjusted EBITDA

Other key measuresEarnings Per ShareQuality of CarePatient Experience

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Hazen$26.5m$78.2m$8.2m$296$148$6.8bn
2024—$23.8m$40.1m$6.1m$189$129$5.8bn
2023—$21.3m$23.6m$6.9m$169$126$5.2bn
2022—$14.6m$9.6m$5.2m$149$124$5.6bn
2021—$20.6m$84.6m$6.0m$158$126$7.0bn

Insiders and the CEO's stakeSelling

3 insiders sold $18.3m in the last six months and none bought.

Open-market trades by officers and directors since May 21, 2026.

  • SoldJon M FosterEVP and COO$15.9mNov 6, 2026
  • SoldErica RossittoSVP & Chief Nurse Executive$1.8mNov 10, 2026
  • SoldMichael J SchlosserEVP and Chief Clinical Officer$594kNov 4, 2026

Leadership and governance on file

20222023202420252026Leadership 17Votes 5
All 17 filings

Latest shareholder vote results: Apr 28, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $38.4bn returned to owners in buybacks and dividends, 127% of net income, and $1.8bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$5.4bn$10.7bn20212022202320242025Shares329m295m276m262m239m
Show the figures
Fiscal year20212022202320242025
Revenue$58.8bn$60.2bn$65.0bn$70.6bn$75.6bn
Net income$7.0bn$5.6bn$5.2bn$5.8bn$6.8bn
Stock-based pay$440.0m$341.0m$262.0m$360.0m$401.0m
Buybacks$8.2bn$7.0bn$3.8bn$6.0bn$10.1bn
Dividends$624.0m$653.0m$661.0m$690.0m$679.0m
Diluted shares329m295m276m262m239m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.